Archive
This is my archive
Averna Therapeutics named one of Endpoints News 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups
Chuck Alpuche Appointed to President and COO of Imperative Care
Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer
Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
TRexBio Expands Leadership Team with Appointments of Ariella Kelman, M.D., as Chief Medical Officer and Brandon Hants, MBA, as Chief Financial Officer
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
Dr. Eric Huang, Operating Partner at Delos, was awarded the 2022 Warren Alpert Foundation Prize
We would like to congratulate Dr. Eric Huang, Operating Partner at Delos Capital for being presented with the prestigious 2022 Warren Alpert Foundation Prize! Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School. 2022 WARREN ALPERT… Read More
Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer
Former CEO and Antios co-founder, Abel De La Rosa, Ph.D., appointed Chairman of the Board of Directors Mayes to lead continued development of ATI-2173 as a potential backbone of a curative regimen for Hepatitis B (“HBV”) ATLANTA, Dec. 01, 2020 (GLOBE NEWSWIRE) — Antios Therapeutics, Inc. (“Antios”) today… Read More